Food Allergy Research & Education

20 articles with Food Allergy Research & Education

• 85 Million Americans Are Impacted by Food Allergies and Intolerances

  5/3/2021

  FARE, the world's leading non-governmental organization engaged in food allergy advocacy and the largest private funder of food allergy research, is excited to announce programming and details around its annual Living TealTM Food Allergy Awareness Week.

• United States House of Representatives Passes FASTER Act for Sesame Labeling

  4/15/2021

  The United States House of Representatives passed the Food Allergy Safety, Treatment, Education and Research Act, a critical piece of legislation requiring that sesame be labeled on packaged foods and prioritizing food allergy research.

• FARE Names Michael Frazier Executive Vice President and Chief Business Officer

  4/12/2021

  FARE, the world's leading non-governmental organization engaged in food allergy advocacy and the largest private funder of food allergy research, announced the addition of Michael Frazier as Executive Vice President and Chief Business Officer.

• FARE Launches Global Research Competition to Develop a Safe & Compassionate Diagnostic Test for Patients with Food Allergies

  3/25/2021

  $3 Million in Prize Money Inspires the World's Leading Food Allergy Researchers to Put an End to the Oral Food Challenge

• FASTER Act for Sesame Labeling Unanimously Passes in the Senate

  3/4/2021

  FARE, the world's leading non-governmental organization engaged in food allergy advocacy and the largest private funder of food allergy research, announced that the Food Allergy Safety, Treatment, Education and Research Act, S. 578, was unanimously passed last night by the United States Senate.

• FASTER Act for Sesame Labeling Introduced in the House of Representatives

  2/23/2021

  FARE, the world's leading non-governmental organization engaged in food allergy advocacy and the largest private funder of food allergy research, announced the bipartisan introduction of the Food Allergy Safety, Treatment, Education and Research Act of 2021 by the U.S. House of Representatives.

• FARE Announces Key Partnerships in Crusade to Advance Food Allergy Research

  1/21/2021

  FARE, the world's leading non-governmental organization engaged in food allergy advocacy and the largest private funder of food allergy research, has awarded two competitive grants to partner institutions that will bolster FARE's 2020 expansion of the FARE Clinical Network, powering advances in food allergy research.

• FARE Co-Sponsored $500,000 Research Grant Awarded to Dr. Alexandra Santos of King's College London

  1/5/2021

  Co-sponsored research award supported by Janssen to fund validation of basophil activation and mast cell activation as biomarkers to diagnose and monitor food allergies

• FARE Announces SEED to Study and Promote Early Introduction of Allergenic Foods to Prevent Food Allergies

  10/15/2020

  Key funder of groundbreaking research on early peanut introduction seeks to slow the recent rise in food allergy prevalence

• FARE Announces Living Teal™ Global Summit Programming

  9/24/2020

  FARE, the world's leading non-governmental organization engaged in food allergy advocacy and the largest private funder of food allergy research, announced the full schedule for its upcoming 2020 Living Teal™ Global Summit.

• Half of People with Food Allergies Report At Least One Allergic Reaction Each Year

  9/21/2020

  Food allergy patient registry informs groundbreaking research, with patient-reported data on numbers and reasons for reactions

• FARE To Grant $15m To The Broad Institute Of MIT And Harvard To Decipher Brain-Gut Connections In Food Allergy

  9/15/2020

  Grant Will Fund Research Projects Aimed at Uncovering Key Insight into Life-Threatening Disease Affecting One in 10 Americans

• FARE Announces Living Teal™ Global Summit Speaker Lineup

  9/10/2020

  Diverse roster of speakers and influencers to cover wide range of topics, reach new audiences, expand awareness of food allergies

• FARE Announces 2020 Contains: Courage® Research Retreat

  9/9/2020

  Virtual two-day event to feature guest appearance by Dr. Anthony Fauci and sessions open to public for the first time ever.

• FARE Clinical Network Reaches 50 Sites with Continued 2020 Expansion, Offers New Options to Food Allergy Community

  9/2/2020

  Food Allergy Centers of Distinction in California, Florida, Illinois and Minnesota increase access to cutting-edge care, more promising future

• New Research Shows One-in-Four American Consumers Do Not Purchase Products Containing the Top 9 Food Allergens

  6/22/2020

  Eighty-five million U.S. consumers managing food allergies spend more than $19 billion annually on specialty food products to avoid allergic reactions or other health consequences—paying five percent more per month than the average consumer—according to new research released from FARE, the largest private funder of food allergy research in the world.

• FARE Clinical Network Celebrates Five Years with Expansion, Further Enhancing State-of-the-Art Patient Care

  6/2/2020

  Food Allergy Research & Education continues innovation through accelerated therapy, diagnostics and prevention strategies

• FDA Guidance Sparks Major Concerns, Exacerbates Fears for 32 Million Americans Amid Pandemic

  5/27/2020

  FARE calls on FDA urging prioritization of food allergies, requests collaboration across food allergy community, industry and FDA on strategy moving forward

• FARE Launches Baby's First: Reduce the Risk of Food Allergies

  4/30/2020

  New Online Hub Dedicated to Raising Awareness and Educating New Parents on the Benefits of Early Introduction   [30-April-2020]   MCLEAN, Va. , April 30, 2020 /PRNewswire/ -- Today, FARE (Food Allergy Research & Education), the world's leading food allergy advocacy organization and the largest private funder of food allergy research, announced the launch of a new reso

• 

  FARE, J&J Fund Research Grant to Discover Food Allergy Biomarkers

  1/8/2020

  FARE said the biomarker research project, which will be conducted at Janssen’s World Without Disease Accelerator, “has the potential to make a real and significant impact for the 32 million Americans living with food allergies.”